Skip to main content
AIBT
OTC Life Sciences

AIBOTICS Reports Zero Revenue, Worsening Liquidity, and Massive Dilution in Q1

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Technology
Sentiment info
Negative
Importance info
9
Price
$0.001
Mkt Cap
$510.926K
52W Low
$0.001
52W High
$0.024
52W Position info
38% above low
Off High info
96% below high
Rel. Volume info
0.2× avg
Market data snapshot near publication time

AIBT sits 38% above its 52-week low of $0.001 on light trading volume (0.2× avg).

Summary

Aibotics, Inc. reported zero revenue and a worsening financial position in Q1 2026, alongside significant share dilution and reiterated 'going concern' and internal control warnings.


Key Events · Earnings and Guidance · AIBT

  • Zero Revenue Reported

    The company generated no revenue for the three months ended March 31, 2026, down from $2,183 in the same period last year.

  • Worsening Liquidity and Going Concern

    The working capital deficit increased to $4.72 million as of March 31, 2026, and the company reiterated its 'going concern' warning due to recurring losses and negative cash flows.

  • Significant Share Dilution

    Aibotics issued approximately 52.4 million common shares for $98.2 thousand in Q1 2026, and an additional 142.5 million shares for $112.9 thousand in subsequent events, representing substantial dilution.

  • Multiple Debt Defaults

    Several convertible notes payable, including those from Lender G (formerly Lender A), Lender B, and Lender E, are in default, with default interest accruing at 20%.


Analysis · AIBT · Life Sciences

Aibotics, Inc. reported zero revenue for the first quarter of 2026, a significant decline from $2,183 in the prior year, highlighting severe operational challenges. The company's financial position deteriorated further with a worsening working capital deficit of $4.72 million and increased cash burn from operations. The filing reiterates a 'going concern' warning and material weaknesses in internal controls, consistent with previous disclosures. To manage liquidity, the company engaged in highly dilutive financing activities, issuing approximately 52.4 million shares for $98.2 thousand in Q1 2026, and an additional 142.5 million shares for $112.9 thousand in subsequent events, representing a substantial portion of its market capitalization. Multiple convertible notes are in default, and a new equity incentive plan for 500 million shares signals potential for further significant dilution.

How filings like this one have moved

In the 30 days to Nov 15, 2026, 52.8% of the 195 measured filings Wiseek scored 9 moved their stock by 5% or more by the next session's close. The median move was -1.69%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, AIBT was trading at $0.00 on OTC in the Life Sciences sector, with a market capitalization of approximately $510.9K. The 52-week trading range was $0.00 to $0.02. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

AIBT - Latest Insights

AIBT
Oct 16, 2026, 4:07 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $0.0021
Real-time Price: $0.0031 info
Change: +$0.0010 (+48%) info
Market Cap: $2.76M info
AIBT
Oct 02, 2026, 6:50 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $0.0022
Real-time Price: $0.0031 info
Change: +$0.0009 (+41%) info
Market Cap: $2.76M info
AIBT
Aug 19, 2026, 5:25 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $0.0004
Real-time Price: $0.0031 info
Change: +$0.0027 (+675%) info
Market Cap: $2.76M info
AIBT
Jun 09, 2026, 6:11 AM EDT
Source: Wiseek News
Importance Score:
7
Price at Filing: $0.0009
Real-time Price: $0.0031 info
Change: +$0.0022 (+244%) info
Market Cap: $2.76M info
AIBT
May 19, 2026, 9:45 AM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $0.0007
Real-time Price: $0.0031 info
Change: +$0.0024 (+343%) info
Market Cap: $2.76M info